FDA labels Duke researchers' device to help extract brain tumors a 'breakthrough'

The Duke Chronicle – A tumor removal tool created at Duke was recently designated a “Breakthrough Device" by the U.S. Food and Drug Administration. This device—called the "Tumor Monorail"—was designed by the Bellamkonda Lab. It works by mimicking the white matter fibers in the brain to trick tumors into moving to locations more accessible by surgeons.

BRCA Exchange aggregates data on thousands of BRCA variants to understand cancer risk

Science Daily – A global resource that includes data on thousands of inherited variants in the BRCA1 and BRCA2 genes is available to the public. The BRCA Exchange was created through the BRCA Challenge, a long-term demonstration project initiated by the Global Alliance for Genomics and Health (GA4GH) to enhance sharing of BRCA1 and BRCA2 data.

How does chemo brain work? One cancer drug might interfere with brain signaling

Science – A new study suggests that in the case of one chemotherapy drug, the debilitating side effect “chemo brain" – which affects millions of cancer patients and causes memory lapses, trouble concentrating, and an all-around mental fog – may be due to brain cells called microglia that  orchestrate chemo brain by disrupting other cells that help maintain the brain’s communication system.